Article
Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsets.
Clinical immunology (Orlando, Fla.) - 1 Aug 2024
Lee Hyun, Lee Miseon, Lim Chae Lyul, Park Hye Seon, Song In Hye, Jeong Byung-Kwan, Kim Dong Kwan, Kim Yong-Hee, Choi Sehoon, Lee Geun Dong, Lee Sae Byul, Jung SungWook, Gong Gyungyub, Kim Sung-Bae, Yoo Changhoon, Kim Joo Young, Lee Hee Jin
Abstract excerpt
Our study aimed to expand tumor-infiltrating lymphocytes (TILs) from primary non-small cell lung cancers (NSCLCs) and evaluate their reactivity against tumor cells. We expanded TILs from 103 primary NSCLCs using histopathological analysis, flow cytometry, IFN-γ release assays, cell-mediated cytotoxicity assays, and in vivo efficacy tests. TIL expansion was observed in all cases, regardless of EGFR mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
